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Infection of calves with bovine herpesvirus 1 (BHV-1) results in transient immunosuppression that may lead
to bacterium-induced pneumonia and, occasionally, death. Although sensory neurons in the trigeminal ganglia
(TG) are the primary site of BHV-1 latency, viral genomes are detected in the tonsils of latently infected calves.
Dexamethasone (DEX) consistently induces reactivation from latency, and viral gene expression is detected in
TG and tonsils. In sensory neurons of latently infected calves, the latency-related (LR) gene is abundantly
expressed and is required for reactivation from latency. In the present study, we compared the abilities of
wild-type (wt) BHV-1 and a strain with a mutation in the LR gene (the LR mutant strain) to grow in the tonsils
of infected calves and reactivate from latency. Lower levels of the LR mutant virus were detected in the tonsils
of acutely infected calves. LR mutant viral DNA was consistently detected by PCR in the tonsils of latently
infected calves, suggesting that the establishment of a latent or persistent infection occurred. Although the LR
mutant did not reactivate from latency in vivo after DEX treatment, explantation of tonsil tissue from calves
latently infected with the LR mutant yielded infectious virus. Relative to wt BHV-1, the LR mutant did not
induce explant-induced reactivation as efficiently. These studies indicate that the LR gene promotes virus
shedding from tonsil tissue during acute infection and reactivation from latency in tonsil tissue in vivo. We
suggest that incorporation of the LR gene mutation into existing modified live vaccines would prevent
reactivation from latency in neural and nonneural sites and would thus prevent transmission to other animals.
Bovine herpesvirus 1 (BHV-1), a member of the Alphaher-
pesvirinae subfamily, is responsible for a variety of clinical
syndromes in cattle, including respiratory disorders, conjunc-
tivitis, genital infections, encephalitis, abortions, and a multi-
systemic fatal disease in neonates. Acute infection of the re-
spiratory tract by BHV-1 can induce immunosuppression,
which predisposes cattle to secondary bacterial colonization,
severe pneumonia, and even death (41).
Peripheral blood mononuclear cells prepared from calves
infected with BHV-1 produce less interleukin 2 and have re-
duced mitogenic responses and lower natural cytotoxic activi-
ties (3). Furthermore, BHV-1 infects and induces at least 50
times more apoptosis in CD4 T cells during acute infection
relative to that induced in mock-infected cells (43, 46). BHV-1
antigens and apoptotic cells can be localized to germinal cen-
ters (GCs) of the pharyngeal tonsils in acutely or latently in-
fected calves. BHV-1 induces apoptosis when cultured T cells,
B lymphocytes, or monocytes are infected (14, 15). Glycopro-
tein D is important for the inducement of apoptosis during the
infection process (12). Diverse mechanisms, such as induction
of c-myc (13), p53 expression, and caspase activation (8), also
stimulate apoptosis following BHV-1 infection. Finally, her-
pesviruses, including BHV-1, interfere with the major histo-
compatibility complex class I antigen presentation pathway
and, consequently, interfere with cytotoxic lymphocyte-medi-
ated killing of virus-infected cells (16, 31; for a review, see
reference 9). Collectively, these studies indicate that the ability
of BHV-1 to infect lymphoid cells and induce apoptosis is
important for pathogenesis.
After acute infection, members of the Alphaherpesvirinae
subfamily establish latent infections in their hosts, primarily in
sensory neurons within trigeminal ganglia (TG) or dorsal root
ganglia (23, 24). Latent virus can periodically reactivate from
latency as a result of natural stressors or dexamethasone
(DEX) treatment, which leads to virus shedding and spread to
susceptible hosts (36, 44, 46). Although ganglionic neurons are
the main site of latency for BHV-1 and other members of the
Alphaherpesvirinae subfamily, latent or persistent infections
can also occur in nonneural sites, for example, tonsils and
lymph nodes. BHV-1 DNA is consistently detected in tonsils
(46), peripheral blood cells (10), lymph nodes, and the spleen
when infectious virus is not detected (30). Pseudorabies virus
(4, 37), equine herpesvirus type 4 (2), and canine herpesvirus
type 1 (28) DNA is also detected in lymphoid tissue during
latency.
A small region of the BHV-1 genome, the latency-related
(LR) gene, is abundantly transcribed in latently infected neu-
rons (26). LR gene RNA is alternatively spliced (7, 17) and can
be translated into more than one protein (22). LR gene pro-
teins are expressed late in the productive infection cycle and
are detected in a subset of latently infected neurons (17, 21). A
BHV-1 strain with an LR gene mutation containing three stop
codons at the beginning of the 5 terminus of the LR gene
transcript (the LR mutant) was recently constructed. The LR
mutant expresses the LR gene transcript but not LR gene
proteins (22). LR mutant and wild-type (wt) strains grow to
similar endpoint titers in cultured bovine cells and in the nasal
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cavity of infected calves (18). However, calves infected with the
LR mutant virus shed virus from the eye at lower titers and
exhibit diminished clinical symptoms compared to the titers
and symptoms in calves infected with wt BHV-1. In addition,
lower levels of infectious virus are present in TG homogenates
prepared from calves infected with the LR mutant relative to
those in wt-infected calves, and calves latently infected with the
LR mutant contain lower levels of viral DNA in TG (19).
Finally, the LR mutant does not reactivate from latency fol-
lowing DEX treatment, in part, because the LR mutant in-
duces higher levels of apoptosis in TG near the end of acute
infection (27). Considering that BHV-1 modified live vaccines
can reactivate from latency and are pathogenic in small calves
(25), incorporation of the LR gene mutation into a modified
live vaccine may prevent reactivation from latency. Thus, un-
derstanding of the pathogenic potential of the LR mutant and
its ability to establish and reactivate from latency in the tonsil
is important for determination of whether the LR gene muta-
tion could be incorporated into a modified live vaccine strain.
In this study, we compared the abilities of LR mutant and wt
viruses expressing LR gene products to grow in the tonsils of
acutely infected calves and to establish and reactivate from
latency. Expression of the LR gene by the wt virus stimulated
the growth of BHV-1 in the tonsils of acutely infected calves.
However, LR gene products do not have a major effect on
apoptosis in the tonsils, perhaps because LR gene RNA is not
abundantly expressed. Similar levels of viral DNA were de-
tected in the tonsils of latently infected calves, regardless of
which virus was used to infect the calves. Although we have no
evidence that the LR mutant can reactivate from latency fol-
lowing DEX treatment of latently infected calves, the LR mu-
tant virus can reactivate from latency when tonsil tissue is
explanted.
MATERIALS AND METHODS
Viruses. The Cooper strain of BHV-1 (wt virus) was obtained from the Na-
tional Veterinary Services Laboratory, Animal and Plant Health Inspection Ser-
vices, Ames, Iowa. To construct the LR mutant virus, 25 bp of the LR gene
sequence that is near the first in-frame ATG of open reading frame ORF-2 was
replaced with an oligonucleotide that contains a unique EcoRI restriction site
and three stop codons to inhibit protein expression (18). This mutation was
rescued by recombining the wt LR gene back into the LR gene locus of the LR
mutant virus, and this strain was designated the LR gene rescued virus.
Animals. BHV-1-free cross-bred calves (weight, 250 kg) were used for this
study. Calves were inoculated with 107 PFU of the indicated virus into each
nostril and eye for a total of 4  107 PFU/animal, as described previously (18,
19). Calves were housed under strict isolation and given antibiotics before and
after BHV-1 infection to prevent secondary bacterial infection. Latently infected
calves were injected intravenously with 100 mg of DEX at 60 days postinfection
(dpi) to initiate reactivation from latency. Two additional intramuscular injec-
tions of DEX (25 mg) were given at 2 and 4 days after the initial injection of
DEX to ensure that reactivation occurred. This protocol induces reactivation
from latency in all calves latently infected with wt BHV-1 (19). All animal
experiments were performed in accordance with the guidelines of the American
Association of Laboratory Animal Care.
Tissue samples. Tonsils and lymph nodes from calves infected with wt BHV-1,
LR gene rescued virus, and the LR mutant were collected from acutely infected
calves at 0, 2, 4, 6, 10, and 14 dpi. Tissue samples were also collected at 60 dpi
(latency) and after DEX treatment to initiate reactivation (1, 2, 21, 28, 30, and
35 days). All tissue samples were stored at 100°C for nucleic acid extraction or
were processed for histological methods.
Tonsil homogenates and virus titration. Homogenates were prepared from
0.5 g of tonsil tissue with a glass tissue grinder as 10% solutions in minimal
essential medium (MEM) containing antibiotics. Tonsil homogenates were cen-
trifuged at 2,000 rpm for 30 min at 4°C (Beckman Avanti 30 centrifuge). The
supernatant (125 l) was added to 500 l of medium (1:5 dilution), and then 1:5
serial dilutions were made. One hundred microliters of each dilution was added
in quadruplicate to a 96-well plate. Each well contained 100 l of MDBK cells
(105 cells). After 4 days of incubation, the virus titer was measured by a 50%
endpoint assay.
Tonsil explants and homogenates. To prepare tonsil explants, tonsil tissue
samples were minced into pieces of approximately 1 mm3 and washed in phos-
phate-buffered saline (PBS) containing antibiotics (penicillin and streptomycin).
Five to six pieces were inoculated into petri dishes and overlaid with 4 ml of
MEM containing 20% fetal bovine serum and antibiotics. MDBK cells were used
as indicator cells for cocultivation of all explant cultures. The medium was
changed every 3 to 4 days, and cultures were observed daily for a cytopathic
effect.
Homogenates were prepared as a 10% solution in MEM containing antibiotics
with glass tissue grinders. Tonsil homogenates were centrifuged at 2,000 rpm for
30 min at 4°C (Beckman Avanti 30 centrifuge). An aliquot of each supernatant
(100 l) was inoculated into MDBK cells in 24-well plates in duplicate. Cultures
were observed daily for a cytopathic effect, and the supernatants were passaged
every 3 days, for a total of four passages. All explant and homogenate cultures
were tested for BHV-1 antigens by direct immunofluorescence with a BHV-1
polyclonal antibody (IBR FA conjugate; American BioResearch Lab). Cultures
in 24-well plates were fixed in methanol-acetone (1:1) for 20 min at 20°C. FA
conjugate diluted 1:50 was applied to each well. After incubation at 37°C for 45
min, the plates were washed three times in PBS and observed by immunofluo-
rescence microscopy.
ISH. DNA probes specific for the BHV-1 glycoprotein C (gC), ribonucleotide
reductase, bICP0, and the LR gene sequences were synthesized and labeled by
PCR in the presence of digoxigenin-dUTP (Boehringer Mannheim Corp., Indi-
anapolis, Ind.), as described previously (43–46). Tissue sections were deparaf-
finized and rehydrated in a graded alcohol series. Deproteinization was carried
out in 0.2 N HCl for 20 min at room temperature. Permeabilization with pro-
teinase K (20 g/ml; Boehringer Mannheim) was performed in PBS for 20 min
at 37°C. After the tissue sections were rinsed with PBS (three times for 5 min
each time), they were fixed with 4% paraformaldehyde in PBS for 5 min at room
temperature. To reduce nonspecific binding of the probes, tissue sections were
subjected to acetylation treatment in 0.1 M triethanolamine-HCl buffer (pH 8.0)
with 0.25% acetic anhydride at room temperature. After 5 min of treatment,
0.25% acetic anhydride was added for an additional 5 min. The slides were then
rinsed in 2 SSC (1 SSC is 150 mM NaCl plus 15 mM sodium citrate [pH 7.0])
for 5 min and then incubated for 1 h at 60°C in 200 l of prehybridization mixture
(in situ hybridization [ISH] mixture with 50% formamide; Amresco). Labeled
probes were subsequently added to the prehybridization mixture, and hybridiza-
tion was performed overnight at 60°C. The slides were then washed twice in 4
SSC for 5 min at room temperature, once in 2 SSC, and once in 0.5 SSC for
5 min at 40°C. The washes were then carried out at room temperature: twice in
2 SSC, twice in 0.5 SSC, and once in buffer I (100 mM maleic acid, 150 mM
NaCl [pH 7.5]) for 5 min each time. The anti-digoxigenin-alkaline phosphatase
conjugate (Boehringer Mannheim) was diluted in buffer II (1% blocking reagent
in buffer I; Boehringer Mannheim), according to the recommendations of the
manufacturer, and incubation was carried out for 1 h at room temperature. The
slides were washed twice in buffer I and then once in buffer III (100 mM
Tris-HCl, 100 mM NaCl, 50 mM MgCl2 [pH 9.5]) for 5 min each time. The slides
were then incubated with color substrate solution consisting of 4-nitroblue tet-
razolium chloride (Boerhinger Mannheim) and 5-bromo-4-chloro-3-indolylphos-
phate (X-phosphate; Boehringer Mannheim) in buffer III. The color reaction
was stopped with TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH 8.0]). The slides
were counterstained with methyl green, and a coverslip was applied with Per-
mount (Fisher).
Nucleic acid extraction. Nucleic acid extraction was performed essentially as
described by Chomczynski and Sacchi (5). Tonsil tissues were minced into small
pieces, placed into 10 ml of solution D (4 M guanidine thiocyanate, 25 mM
sodium citrate [pH 7.0], 0.5% sarcosyl, 14 mM -mercaptoethanol), and homog-
enized. Two phenol extractions were performed, and the interface was saved for
DNA extraction. The DNA was suspended in TEN buffer (50 mM Tris [pH 7.5],
100 mM NaCl, 10 mM EDTA) containing 0.5% sodium dodecyl sulfate and 0.3
mg of proteinase K/ml. This solution was digested overnight at 55°C. The DNA-
containing solution was then extracted once with phenol-chloroform-isoamyl
alcohol (25:24:1), precipitated with 2 volumes of ethanol, and suspended in
Tris-EDTA to a final concentration of 1 g/l.
PCR. An aliquot (2 l) of DNA was used for each PCR with primers specific
for the BHV-1 gC gene. The primers were GAGCAAAGCCCCGCCGAAGGA
(forward primer) and TACGAACAGCAGCACGGGCGG (reverse primer).
PCR was carried out in a 50-l mixture containing 1 commercial PCR buffer,
200 M each deoxynucleoside triphosphate, 1 M each primer, and Taq poly-
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merase. Amplification of the target was carried out for 40 cycles by denaturation
at 95°C for 1 min, annealing at 65°C for 1 min, and extension at 72°C for 2 min.
After the last cycle, the reaction mixtures were further incubated at 72°C for 7
min to ensure complete extension of the amplified product.
The amount of viral DNA in latently infected tonsils was assessed by semi-
quantitative PCR with BHV-1 gC gene-specific primers. The bovine growth
hormone (GH) gene was amplified with the following primers (forward primer,
GCTTTCGCCCTGCTCTGCC; reverse primer, TCCTGCCTCCCCACCCC
TA). GH gene-specific primers were used to ensure that similar amounts of
starting material were included in each reaction mixture. To demonstrate that
the strategy used for the semiquantitative analysis was valid over a range of DNA
concentrations, 10-fold dilutions of the positive control were amplified (30 cy-
cles) in each assay to generate a standard curve. This ensured a linear relation-
ship between the initial input DNA and the intensity of the product amplified
from the gene for GH. The respective bands were captured by using a Bio-Rad
FX Pro Plus device, and then the bands were quantified with Quantity One
software (Bio-Rad).
In situ detection of apoptosis. Tissue sections were deparaffinized in xylene for
10 min, rehydrated in a graded ethanol series, and treated with proteinase K (20
g/ml; Gibco BRL). Proteinase K treatment was conducted with Tris buffer (100
mM Tris-HCl, 150 mM NaCl [pH 7.6]) for 20 min at 37°C. Nick end labeling of
the DNA strand breaks in consecutive tissue sections was performed by the
terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
(TUNEL) assay, which uses alkaline phosphatase (Boehringer Mannheim). The
slides were counterstained with methyl green, and then a coverslip was placed
with Permount (Fisher). Apoptosis was evaluated in the following tonsillar com-
partments: GCs, crypts, epithelium, and interfollicular zones. The apoptotic cells
observed in 10 different fields of each compartment were counted, and an
intensity score was assigned on the basis of the average number of apoptotic cells
counted for each tonsillar compartment. Scores were as follows: 0, no apoptotic
cells; 1, 1 to 50 apoptotic cells; 2, 51 to 200 apoptotic cells; 3, 201 to 400 apoptotic
cells; 4, 401 to 600 apoptotic cells; 5, 601 to 800 apoptotic cells; 6,800 apoptotic
cells. Statistical analysis was performed by the Kruskal-Wallis test for nonpara-
metric data. The model statement included treatment (mock-infected, wt-in-
fected, and LR mutant-infected calves), animal (treatment), day, tonsillar com-
partment, and their interactions (treatment-day, treatment-compartment, and
treatment-day-compartment interactions). A 5% significance level was used.
Means were compared by the Tukey-Kramer test at a 5% significance level.
RESULTS
Localization of viral DNA in tonsils by ISH. ISH was per-
formed to localize the viral DNA in tonsil tissue during acute
infection and latency following infection with the LR mutant or
wt BHV-1. BHV-1-specific digoxigenin-labeled probes specific
for four viral genes (the gC, bICP0, ribonucleotide reductase,
and LR genes) were used for these studies. ISH-positive cells
were consistently detected 2, 6, and 10 days after infection in
the tonsils of calves infected with wt BHV-1 (Fig. 1A to C).
Strong positive signals were primarily detected in areas adja-
cent to tonsillar crypts (Fig. 1B and C). Positive ISH signals
were not readily detected in tonsil sections prepared from
calves infected with the LR mutant during acute infection
(data not shown). Viral DNA was not detected in the tonsils of
mock-infected calves (Fig. 1D) or in the tonsils of calves la-
tently infected with the LR mutant or wt BHV-1 (data not
shown).
Retropharyngeal and cervical lymph nodes, which drain
from the initial site of infection, were also analyzed. Positive
ISH signals were not readily detected with these tissues, re-
gardless of the virus used to infect the calves (data not shown).
A slight increase in the number of secondary lymphoid follicles
was observed in the retropharyngeal lymph nodes but not in
the cervical lymph nodes. Pathological differences in the lymph
nodes of calves infected with the wt versus the LR mutant were
not readily observed. In summary, these studies indicated that
wt BHV-1 is readily detected by ISH in tonsils during acute
infection, whereas LR mutant viral DNA is not.
Detection of viral DNA in tonsils of infected calves by PCR.
PCR assays were used to test whether viral DNA was present
in the tonsils of calves infected with the LR mutant because the
ISH results were negative. PCR was performed with gC-spe-
cific primers to detect viral DNA in pharyngeal tonsils at dif-
ferent times postinoculation. In wt-infected calves, the gC-
specific amplification product was detected in the tonsils of
both animals at 2 and 6 dpi and in one of two animals at 4 dpi
(Fig. 2A). The expected 229-bp product was detected in the
tonsils of both calves in the LR mutant-infected group at 2, 4,
and 6 dpi (Fig. 2B). At 10 and 14 dpi, one of two calves con-
tained detectable levels of viral DNA when the calves were
infected with the LR mutant (Fig. 2B). Viral DNA was not read-
ily detected in the tonsils at 14 dpi when the calves were in-
fected with wt BHV-1 (Fig. 2A). Although amplified bands
were detected in mock-infected MDBK cells (Fig. 2A), none of
these bands was the specific amplified gC product. The ISH and
PCR results suggest that lower levels of LR mutant viral DNA
were present in the tonsil tissues of acutely infected calves.
Previous studies demonstrated that lower levels of viral
DNA were present in TG of calves latently infected with the
LR mutant relative to the levels in calves latently infected with
wt BHV-1 (19). Thus, it was of interest to test whether this was
the case in the tonsils of calves latently infected with the two
virus strains. We initially attempted real-time PCR, but the
background levels of fluorescence in mock-infected samples
and the control with no template were too high (data not
shown). Consequently, we performed semiquantitative PCR
using the gC-specific primers and bovine GH-specific primers
to normalize the samples. The GH-specific primers were used
to establish a standard curve for estimation of the levels of gC
in tonsil tissue. This approach had an advantage, in that we
knew the sizes of the amplified bands and were able to com-
pare the intensities of the bands in the respective samples. In
contrast to the results obtained with TG (19), similar levels of
viral DNA were present in tonsils during latency (60 dpi) (Fig.
3). In summary, these studies demonstrated that the LR mu-
tant viral DNA was present in the tonsils of latently infected
calves and that similar levels of viral DNA were present in the
tonsils during latency.
Isolation and titration of virus present in tonsils of acutely
infected cattle. Infectious virus was isolated from two of two
tonsils from calves infected with wt BHV-1 or the LR gene
rescued virus at 2, 4, 6, and 10 dpi. The LR mutant strain was
isolated from two of two tonsils at 2 and 6 dpi but from just one
of two tonsils at 4 and 10 dpi. No infectious virus was recovered
at 14 dpi, regardless of whether the calves were infected with
wt BHV-1, the LR gene rescued virus, or the LR mutant. As
expected, samples prepared from mock-infected calves were
negative for virus isolation.
In general, 2 to 3 log units less virus was detected in homog-
enates prepared from calves infected with the LR mutant
strain than from calves infected with the wt virus (Fig. 4). The
exception to this was at 6 dpi, when virus titers from tonsil
homogenates prepared from calves infected with the LR mu-
tant were slightly higher than those from calves infected with
wt BHV-1. This result suggests that virus infection was delayed
in the tonsils of calves infected with the LR mutant and that, in
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general, the LR mutant grew less efficiently in the tonsils of
infected calves. The decreased growth of the LR mutant in the
tonsils was similar to the results obtained with TG and the eye
(18, 19).
Analysis of apoptosis in tonsil tissue. A previous study dem-
onstrated that calves infected with BHV-1 contain numerous
TUNEL assay-positive cells in their pharyngeal tonsils (43). In
agreement with this finding, apoptosis was detected in the
tonsils of the infected (Fig. 5A to E) and the noninfected (Fig.
5F) calves used for this study. Apoptotic cells were observed in
all tonsillar compartments analyzed. Although apoptosis was
detected in calves infected with the LR mutant (Fig. 5C and
D), during the course of acute infection there appeared to be
reduced levels in these calves compared to the levels in calves
infected with wt BHV-1 or the LR gene rescued virus.
To determine the frequency of apoptosis in the tonsils of
infected calves, the number of apoptotic cells in the tonsils of
calves infected with wt BHV-1 was counted, and these results
were compared to the apoptotic frequency in calves infected
with the LR mutant or mock-infected calves. Significant dif-
FIG. 1. ISH of bovine tonsils after infection. Tonsil sections of calves at 2 (A), 6 (B), and 10 (C) dpi with wt BHV-1. (D) Representative tonsil
sections from mock-infected calves. ISH was performed with the cocktail of viral probes described in Materials and Methods. The arrows denote
the position of viral nucleic acid positive cells in the tonsil. Magnifications, 1 (A and D) or 40 (B and C).
FIG. 2. PCR of DNA from tonsils at different times after infection.
Calves were infected with wt BHV-1 (A) or the LR mutant strain
(B) as described in the Materials and Methods. Data representative of
those for two calves are shown for each day postinfection (as indicated
by the numbers above the lanes). PCR was performed as described in
Materials and Methods with gC BHV-1-specific primers that yield a
229-bp product (arrows). The gC band was excised and sequenced to
confirm that it was the amplified product. PCR products were electro-
phoresed on 2% agarose gels, and the DNA was stained with ethidium
bromide. The first (unlabeled) lane contains a 100-bp ladder (New
England Biolabs). Mock-infected MDBK cells (lanes M) and MDBK
cells infected with BHV-1 Cooper strain (lanes C) were included in
all PCRs as negative and positive controls, respectively. Closed circle,
positions of primer dimers or bands resulting from mispriming.
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ferences (P  0.01) in the number of apoptotic cells were
detected in the different regions of the tonsils during acute
infection (Fig. 6A). Analysis of apoptosis in the different ton-
sillar compartments revealed that the highest mean score of
apoptotic cells was observed in tonsils from calves acutely
infected with wt BHV-1. The highest score of TUNEL assay-
positive cells for wt infection was observed in GCs. Statistically
significant differences (P  0.05) in the scores for GCs of
calves infected with wt BHV-1 compared to the scores for the
tonsils of calves infected with the LR mutant strain or the
control group were detected (Fig. 6A).
For the interfollicular zone and tonsillar crypts, significant
differences were not detected (P 	 0.05) when mock-infected
calves were compared to calves infected with the LR mutant. A
high score for apoptotic cells was observed in the epithelia of
the tonsils from mock-infected calves, but this score was not
significantly different (P 	 0.05) from the score for calves
infected with wt BHV-1 (Fig. 6A).
The effect of time after infection on the apoptotic score was
analyzed independently of the treatment (Fig. 6B). These re-
sults demonstrated that wt BHV-1 and the LR mutant strain
followed the same pattern with respect to the induction of
apoptosis in tonsils during acute infection. The highest score
for apoptotic cells was detected at 4 dpi, although it was not
statistically different (P 	 0.05) from the scores detected at 2
and 10 dpi. By 14 dpi, when latency was established (23, 24), a
reduction in the scores for TUNEL assay-positive cells was
detected. The mean score at day 14 was statistically different
(P  0.05) from those at day 2, 4, and 10 but not from that at
day 6 (P  0.05). In summary, these studies confirmed that
apoptosis occurs in the tonsils of infected calves. With respect
to GCs, higher frequencies of apoptosis were detected in calves
infected with wt BHV-1, which correlated with the higher titers
of virus in the tonsils of calves infected with wt BHV-1.
The LR mutant can reactivate in explanted tonsil tissue. In
our previous studies (19), we were not able to detect infectious
virus from calves latently infected with the LR mutant follow-
ing DEX treatment. In contrast, in all calves infected with wt
BHV-1 or the LR mutant rescued virus, virus was reactivated
from latency because infectious virus was readily detected and
the BHV-1-specific antibody titers increased after DEX treat-
ment. When the wt LR gene (32) was inserted into a herpes
simplex virus type 1 (HSV-1) LAT null mutant, the resulting
recombinant virus was capable of high levels of spontaneous
reactivation in a rabbit ocular model. In contrast, the LAT null
mutant exhibits low levels of spontaneous reactivation from
latency (29, 32–35). When the LR gene containing the stop
codons used to generate the LR mutant virus strain was in-
serted into the LAT null mutant, this recombinant virus be-
haved like the LAT null HSV-1 mutant (29). These studies
indicate that the LR gene plays a crucial role during the laten-
cy-reactivation cycle.
It is possible to take TGs from mice or rabbits that are
latently infected with HSV-1 and to explant the tissue and
generate infectious virus (29, 32, 33, 39). In this assay, HSV-1
LAT is also important for the promotion of explant-induced
reactivation. Consequently, we tested whether infectious virus
could be detected when tonsil tissue from latently infected
calves or calves that were latently infected and then treated
with DEX were explanted. Infectious virus was detected when
tonsil tissue from calves latently infected with LR gene-positive
BHV-1 strains (the wt or the LR gene rescued virus) was
explanted by 10 days after explantation (15 of 18 calves; Table
1). When tonsil tissues from calves latently infected with the
LR mutant were explanted, 6 of 13 animals yielded infectious
virus, but virus was not generally detected until 15 to 18 days
after explantation (Table 2). As expected, infectious virus was
not detected when tonsil tissue from mock-infected calves was
explanted (Table 1 and 2). These studies indicate that the LR
FIG. 3. Quantitation of viral DNA in the pharyngeal tonsils of
latently infected cattle. Semiquantitative PCR was performed with the
virus-specific gC and the bovine GH gene-specific primers described in
the Materials and Methods. A standard curve was used to measure the
intensities of the GH amplification products and was generated with
10-fold serial dilutions of DNA. Under the PCR conditions used, the
intensity of the GH gene band was linear when 0.6 to 0.00006 g of
total DNA from tonsil was used. The amount of total DNA used to
detect the level of the gC-amplified product in the respective samples
was within the linear range of PCR amplification. Two calves infected
with the LR mutant (LR-mut) and two calves infected with wt BHV-1
were then analyzed at 60 dpi (latency). The gC-specific primers do not
amplify the 229-bp gC-specific band with tonsil tissue samples from
mock-infected animals (Fig. 2). The images of the ethidium bromide-
stained gels were captured with a Bio-Rad FX Pro Plus device, and the
bands were quantified and then compared to the standard curve gen-
erated with the GH gene. The values presented are expressed as the
amount of viral DNA/micrograms total DNA present in the tonsil.
FIG. 4. Isolation and titration of virus present in tonsils during
acute infection. Virus was isolated from tonsils of mock-infected (day
0), LR mutant-infected, or wt-infected calves at different times after
infection, as described in the Material and Methods. Virus titration
was performed with MDBK cells, and the data represent the average
for each group. Two calves in each group were used for this study.
Negative results are represented by a value of 0.2 in order to visualize
the bars.
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FIG. 5. TUNEL assay with tonsil tissues of calves during acute infection. The TUNEL assay was performed as described in the Materials and
Methods. Shown are tonsil tissue sections from wt BHV-1-infected calves at 2 (A), 4 (B), and 14 (E) dpi and from LR mutant-infected calves at
4 (C) and 6 (D) dpi. (F) Results for a mock-infected calf. The arrows denote areas of TUNEL assay-positive cells.
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FIG. 6. Analysis of apoptosis in tonsils of calves infected with the LR mutant-, wt BHV-1-, or mock-infected calves. (A) Mean scores for
apoptotic cells in different compartments of the tonsils of mock-, LR mutant-, or wt-BHV-1-infected calves. The results of the treatment-tonsil
compartment interaction (P  0.01) are shown. The number of apoptotic cells in consecutive tonsil tissue sections that stained positive by the
TUNEL assay was counted as described in the Materials and Methods. The intensity score represents the average number of apoptotic cells
counted in each tonsil compartment. The number of apoptotic cells in the epithelium infected with the wt was similar to the number in the epithelia
infected with the LR mutant and mock infected, and this is denoted ab. Columns with different letters within each group are significantly different
(P  0.05). (B) Comparison of the frequencies of apoptosis in the tonsils of calves infected with BHV-1. Overall differences in the scores of
apoptotic cells in the tonsils at different times postinfection were not detected between wt BHV-1- and LR mutant-infected calves (P 	 0.05).
Therefore, the scores for apoptotic cells were analyzed independently of those for the infected group. The score at each time represents the average
number of apoptotic cells counted on each day. Columns with different letters denote significant differences (P  0.05) in the scores for apoptotic
cells at different times after infection.
TABLE 1. Results for wt BHV-1 and LR gene rescued virus from tonsil explants and homogenates during latencya
Parameter Mockinfected
Latently
infected
(wt)
DEX,
24 h
(wt)
DEX,
48 h
(wt)
DEX,
21 days
(wt)
DEX,
28 days (wt)
DEX,
35 days (wt)
DEX,
30 days (LR-R)
Calf no. 44 52 42 63 228 245 71 72 50 44 3196 3198 51 54 54 57 65 1 2 124 142
Explant infection result                     
Homogenate infection result                     
a Tonsils from calves that were latently infected (60 dpi) with wt BHV-1 (wt) or the LR rescued virus (LR-R) were used to examine cell-free homogenates for
infectious virus or to perform explant-induced reactivation. Samples were also obtained from latently infected calves after they were treated with DEX, as described
in the Materials and Methods, to initiate reactivation from latency. The times after DEX initiated reactivation, in hours or days, are indicated. The procedures used
to examine explant-induced reactivation and prepare the homogenates to identify cell-free virus are described in the Materials and Methods. The calf identification
number is indicated because these numbers were arbitrarily assigned when the animals were purchased.
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mutant virus is capable of undergoing explant-induced reacti-
vation in the tonsils of latently infected calves but that the
explant-induced reactivation is not as efficient as that obtained
with wt BHV-1.
DISCUSSION
In this study, we compared the ability of wt BHV-1 and the
LR mutant virus to grow in the tonsils of acutely infected
calves and to establish and reactivate from latency in the ton-
sils. Previous studies with the LR mutant strain demonstrated
that LR gene products promote virus growth in certain cell
types during acute infection of cattle, for example, the eye and
TG (18, 19). The present study demonstrated that the LR gene
stimulated growth in tonsil tissue. Although the LR mutant
was not consistently detected in the tonsils by ISH, sensitive
PCR studies demonstrated that LR mutant DNA was present
in the tonsils of acutely and latently infected calves. The finding
that similar levels of viral DNA were detected in the tonsils of
calves latently infected with the LR mutant or wt BHV-1 im-
plies that small amounts of cells in the tonsil and/or circulating
blood survive infection. The LR mutant established a persis-
tent or latent infection in the tonsils but was not able to reac-
tivate from latency in vivo after DEX treatment.
Our studies suggest that the LR gene stimulates virus growth
in the tonsils because there is reduced growth of the LR mu-
tant in the tonsils. Since the LR mutant grows in the nasal
cavity to titers similar to those of wt BHV-1 (18), we suggest
that similar levels of the respective viruses reached the tonsil.
Although there was less virus growth during acute infection,
similar levels of LR mutant and wt BHV-1 DNA were present
in the tonsils of latently infected calves, indicating that the LR
mutant establishes a persistent or latent infection in the tonsils.
Our previous studies (19) demonstrated that the LR mutant
did not reactivate from latency following DEX treatment,
which led us to conclude that the LR gene is necessary for in
vivo reactivation. In this study, we found that the LR mutant
virus was capable of explant-induced reactivation, indicating
that the LR mutant DNA is infectious following the establish-
ment of latency in calves. Explant-induced reactivation is an ex
vivo process, and thus, the immune response is not a significant
limiting factor for virus growth and spread. Our results suggest
that expression of LR gene products interfered with immune
recognition of latently infected cells undergoing reactivation
from latency. Furthermore, the ability of the LR gene to inhibit
apoptosis (6) may allow maximal virus shedding during reac-
tivation from latency in vivo, which is crucial for a successful
reactivation episode in cattle. Finally, LR gene products may
promote productive infection following a stress response in
vivo because DEX was used to initiate reactivation from la-
tency in cattle.
A previous study (27) demonstrated that the LR mutant
induces higher levels of apoptosis near the end of acute infec-
tion, despite reduced virus shedding in TG. In contrast to the
results obtained in TG, the LR gene did not play a dramatic
role in regulating apoptosis in the tonsil, in part because it is
not abundantly expressed. Although LR gene RNA is abun-
dantly expressed in TG of infected calves (23, 24), LR gene
RNA is not abundantly expressed in tonsil tissue prepared
from latently infected calves (46; S. Perez; unpublished data),
suggesting that proteins encoded by the LR gene are not abun-
dantly expressed. Neuron-specific splicing of the LR gene tran-
script also occurs (7, 17), suggesting that proper splicing does
not occur in the tonsil, and thus, LR gene proteins may not
have potent antiapoptotic activity.
Apoptotic cells were detected in all tonsillar compartments
examined, regardless of the virus that was used to infect calves.
However, the highest level of apoptosis was detected in GCs
and, to a lesser extent, interfollicular zones. GCs provide a
specialized environment where B cells initiate the maturation
program after the primary encounter with the antigen in the
extrafollicular T-cell-rich zone (11). Other viruses that infect
lymph nodes or lymphoid cells, such as human immunodefi-
ciency virus (1), human herpesvirus 6 (20), and human herpes-
virus 7 (38), induce the apoptosis of surrounding uninfected
cells (bystander effect) because many T cells express Fas and
the Fas ligand. The ability of viruses to induce apoptosis in a
direct manner and by the bystander effect is an important
mechanism for inducing immunosuppression (47). The ability
of BHV-1 to induce apoptosis in CD4 T cells in a direct
manner (43) and by the bystander effect would contribute to
transient immunosuppression during acute infection.
Although several commercially modified live vaccines di-
rected against BHV-1 are available (42), these vaccine strains
can establish latency and reactivate from latency (25, 40). Re-
activation from latency does not frequently lead to recurrent
disease, but it is the major means of BHV-1 transmission in the
field. Since the existing modified live vaccines can be patho-
genic in small calves and can cause abortion (42), it would be
desirable to generate a vaccine strain of BHV-1 that does not
reactivate from latency. Introduction of the LR gene mutation
into the strain included in the present modified live vaccines
that are commercially available may offer protection from chal-
TABLE 2. Results for LR mutant virus from tonsil explants and homogenates during latencya
Parameter Mockinfected
Latently
infected
DEX,
24 h
DEX,
48 h
DEX,
21 days
DEX,
28 days
DEX,
35 days
Calf no. 33 44 45 49 74 233 230 231 234 43 47 1001 3197 52 63
Explant infection result               
Homogenate infection result               
a Tonsils from calves that were latently infected (60 dpi) with the LR mutant virus were used to examine cell-free homogenates for infectious virus or to perform
explant-induced reactivation. Samples were also obtained from latently infected calves after they were treated with DEX, as described in the Materials and Methods,
to initiate reactivation from latency. The times after DEX initiated reactivation, in hours or days, are indicated. The procedures used to examine explant-induced
reactivation and prepare the homogenates to identify cell-free virus are described in the Materials and Methods. The calf identification number is indicated because
these numbers were arbitrarily assigned when the animals were purchased.
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lenge with a field strain, but the virus in the modified live
vaccine would not reactivate from latency.
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